Advanced Search
LI Xiaoyu, HUANG Qing, WU Yumeng, HU Sheng. The Global Cancer Statistics Report in 2022: A Narrow Spectrum Summary and Outlook[J]. Cancer Research on Prevention and Treatment, 2024, 51(5): 307-312. DOI: 10.3971/j.issn.1000-8578.2024.24.0437
Citation: LI Xiaoyu, HUANG Qing, WU Yumeng, HU Sheng. The Global Cancer Statistics Report in 2022: A Narrow Spectrum Summary and Outlook[J]. Cancer Research on Prevention and Treatment, 2024, 51(5): 307-312. DOI: 10.3971/j.issn.1000-8578.2024.24.0437

The Global Cancer Statistics Report in 2022: A Narrow Spectrum Summary and Outlook

Funding: 

Foundation of Hubei Provincial Administration of Traditional Chinese Medicine ZY2023M0140

Wuhan Knowledge Innovation Foundation 2022020801020513

Wuhan Knowledge Innovation Foundation 2023020201010175

More Information
  • Corresponding author:

    HU Sheng, E-mail: ehusmn@163.com

  • Received Date: May 13, 2024
  • Revised Date: May 15, 2024
  • Available Online: May 14, 2024
  • According to the global cancer statistics in 2022 updated by the International Agency for Research on Cancer (IARC), there were nearly 20 million new cases of cancer and 9.7 million deaths. Lung cancer was the most commonly diagnosed cancer, accounting for nearly 2.5 million new cases (12.4% of all global cancers), followed by female breast cancer (11.6%), colorectal cancer (9.6%), prostate cancer (7.3%), and stomach cancer (4.9%). Lung cancer was also the leading cause of cancer deaths, with an estimated 1.8 million deaths (18.7%), followed by colorectal cancer (9.3%), liver cancer (7.8%), female breast cancer (6.9%), and stomach cancer (6.8%). Population-based projections suggest that the number of new cancer cases will reach 35 million by 2050. Increasing the investment in prevention and control measures targeting key cancer risk factors, including smoking, obesity, and infections, could save many lives globally and bring significant economic and social returns to countries in the coming decades.

  • Competing interests: The author declares that she has no competing interests.

  • [1]
    Frick C, Rumgay H, Vignat J, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study[J]. Lancet Glob Health, 2023, 11(11): e1700-e1712. doi: 10.1016/S2214-109X(23)00406-0
    [2]
    Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. doi: 10.3322/caac.21834
    [3]
    International Agency for Research on Cancer, World Health Organization. CANCER TODAY website updated with GLOBOCAN 2022 database version 1.0[DB/OL]. [2024-01-02]. https://gco.iarc.who.int/today/en/dataviz/treemap?mode=population.
    [4]
    Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070[J]. Nat Rev Clin Oncol, 2021, 18(10): 663-672.
    [5]
    Wild CP, Weiderpass E, Stewart BW. Word Cancer Report: Cancer Research for Cancer Prevention[EB/OL]. https://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-Cancer-Research-For-Cancer-Prevention-2020.
    [6]
    The ASCO Post Staff. GLOBOCAN 2020 Database Provides Latest Global Data on Cancer Burden, Cancer Deaths[DB/OL]. (2020-12-22)[2021-01-27]. https://ascopost.com/news/december-2020/globocan-2020-database-provides-latest-global-data-on-cancer-burden-cancer-deaths/.
    [7]
    Ahmedin J, Lindsey T, Isabelle S, et al. The Cancer Atlas[M/OL]. (2019-10-16). https://canceratlas.cancer.org/wp-content/uploads/2019/10/ACS_CA3_Book.pdf.
  • Related Articles

    [1]SHEN Yijun, HU Wenbin, NI Bin. Disease Burden and Indirect Economic Burden Due to Lung Cancer from 1981 to 2020 in Kunshan, Jiangsu Province, China[J]. Cancer Research on Prevention and Treatment, 2024, 51(2): 121-126. DOI: 10.3971/j.issn.1000-8578.2024.23.0930
    [2]ZHAO Chao, LI Mingzhu, WEI Lihui. Eliminat Cervical Cancer, Focusing on Primary Prevention[J]. Cancer Research on Prevention and Treatment, 2023, 50(11): 1039-1044. DOI: 10.3971/j.issn.1000-8578.2023.23.0691
    [3]LIANG Cuilyu, ZHANG Yin, CHEN Qiying, ZHUO Pingping. Efficacy of Multiple Drugs in Preventing Chronic Peripheral Neuropathy Induced by Platinum and Taxane: A Network Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2022, 49(2): 128-140. DOI: 10.3971/j.issn.1000-8578.2022.21.0675
    [4]YANG Huan, WANG Xiaokun, FAN Jinhu. Present Status of Epidemiology, Risk Factors and Screening of Pancreatic Cancer in China[J]. Cancer Research on Prevention and Treatment, 2021, 48(10): 909-915. DOI: 10.3971/j.issn.1000-8578.2021.21.0789
    [5]WEI Lijuan, LI Lijuan, LIU Juntian. Research Progress and Prevention Strategies of Interval Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2021, 48(2): 182-185. DOI: 10.3971/j.issn.1000-8578.2021.20.0626
    [6]SI Yiran, YUE Jian, LIU Zhaoyang, LI Mo, ZHENG Yuanyi, WANG Xiaobing, YUAN Peng. Immune Mechanism of Tumor Cell Lysate Combined with IL-2 Preventing Melanoma and Inhibiting Tumor Growth[J]. Cancer Research on Prevention and Treatment, 2021, 48(2): 115-120. DOI: 10.3971/j.issn.1000-8578.2021.20.0606
    [7]ZHOU Juan, LIU Yangchen. Evaluation of Compliance to NCCN Clinical Practice Guidelines in Oncology-Antiemesis (Version 1.2014) and Economics of 5-HT3 Receptor Antagonists in Preventing Nausea and Vomiting[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 392-395. DOI: 10.3971/j.issn.1000-8578.2016.05.015
    [8]HU Guangyu, MAO Ayan, DONG Pei, YAN Xiaoling, QIU Wuqi. Discovery Approach and Economic Burden of Six Kinds of Common Cancers Patients in Beijing[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 171-176. DOI: 10.3971/j.issn.1000-8578.2015.02.016
    [9]YAN Qing dong. Clinical Application Value and Prevention of Complication about Puncture Biopsy to Lung Disease under CT Direction[J]. Cancer Research on Prevention and Treatment, 2004, 31(11): 700-701. DOI: 10.3971/j.issn.1000-8578.2078
    [10]FAN Rui-fang, LI Wen-hui, GU Shu-nan. Analysis of Pathogenesis,Prevention and Treatment of Implantation Metastases of Abdominal Wall[J]. Cancer Research on Prevention and Treatment, 2000, 27(01): 55-56. DOI: 10.3971/j.issn.1000-8578.2025

Catalog

    Figures(4)

    Article views (11079) PDF downloads (3216) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return